Moderna
MRNA
#797
Rank
ยฃ19.24 B
Marketcap
ยฃ50.05
Share price
-3.43%
Change (1 day)
-40.52%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2024 (TTM): ยฃ3.98 B

According to Moderna 's latest financial reports the company's current revenue (TTM) is ยฃ3.80 B. In 2023 the company made a revenue of ยฃ5.30 B a decrease over the revenue in the year 2022 that were of ยฃ15.60 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ3.98 B-24.92%
2023 ยฃ5.30 B-66.02%
2022 ยฃ15.60 B19.05%
2021 ยฃ13.10 B6420.45%
2020 ยฃ0.20 B455.24%
2019 ยฃ36.19 M-62.38%
2018 ยฃ96.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.60 B 1,152.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.06 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.78 B-53.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.22 B 879.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ14.97 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ65.96 B 1,635.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.14 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA